Elimination of Amyloid β from the Brain, its Failure in Alzheimer's Disease and Implications for Therapy

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Second Edition

Volumn , Issue , 2011, Pages 97-101

  Weller, Roy O ^a   Love, Seth ^b   Nicoll, James A R ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid ; Cerebral amyloid angiopathy; Immunotherapy; Lymphatic drainage; Neprilysin; Vascular basement membranes

Indexed keywords

EID: 84883626496     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444341256.ch12     Document Type: Chapter

References (33)

1. Revesz T, Holton JL, Lashley T et al. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 2009; 118: 115-130.
2. Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 2009; 117: 1-14.
3. Roher AE, Esh CL, Kokjohn TA et al. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement 2009; 5: 18-29.
4. Herzig MC, Van Nostrand WE, Jucker M. Mechanism of cerebral betaamyloid angiopathy: murine and cellular models. Brain Pathol 2006; 16: 40-54.
5. Love S, Miners S, Palmer J, Chalmers K, Kehoe P. Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Front Biosci 2009; 14: 4778-4792.
6. Bell RD, Zlokovic BV. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009; 118: 103-113.
7. Weller RO, Preston SD, Subash M, Carare RO. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther 2009; 1(2): 6.
8. Szentistvanyi I, Patlak CS, Ellis RA, Cserr HF. Drainage of interstitial fluid from different regions of rat brain. Am J Physiol 1984; 246: F835-844.
9. Carare RO, Bernardes-Silva M, Newman TA et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries. Significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 2008; 34: 131-144.
10. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 2008; 18: 253-266.
11. Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004; 45: 545-552.
12. Syková E, Nicholson C. Diffusion in brain extracellular space. Physiol Rev 2008; 88: 1277-1340.
13. McLean CA, Cherny RA, Fraser FW et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 1999; 46: 860-866.
14. Shinkai Y, Yoshimura M, Ito Y et al. Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra-and intracranial blood vessels. Ann Neurol 1995; 38: 421-428.
15. Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S. Abetadegrading enzymes in Alzheimer's disease. Brain Pathol 2008; 18: 240-252.
16. Eckman EA, Eckman CB. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 2005; 33: 1101-1105.
17. Pahnke J, Wolkenhauer O, Krohn M, Walker LC. Clinico-pathologic function of cerebral ABC transporters-implications for the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2008; 5: 396-405.
18. Hawkes C, McLaurin J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci USA 2009; 106: 1261-1266.
19. Miners JS, van Helmond Z, Kehoe PG, Love S. Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme. Brain Pathol 2010; 20: 794-802.
20. Weller RO, Boche D, Nicoll JA. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 2009; 118: 87-102.
21. Beach TG, Potter PE, Kuo YM et al. Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition. Neurosci Lett 2000; 283: 9-12.
22. Wyss Coray T, Lin C, Sanan DA, Mucke L, Masliah E. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol 2000; 156: 139-150.
23. Schley D, Carare-Nnadi R, Please CP, Perry VH, Weller RO. Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol 2006; 238: 962-974.
24. Wisniewski HM, Wegiel J. Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol (Berl) 1994; 87: 233-241.
25. CFAS NGoM. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169-175.
26. Walsh DM, Selkoe DJ. Abeta oligomers-a decade of discovery. J Neurochem 2007; 101: 1172-1184.
27. Roher AE, Kuo Y-M, Esh C et al. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 2003; 9: 112-122.
28. Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, Roos RA, Frosch MP, Greenberg SM. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol 2006; 16: 30-39.
29. Ueberham U, Ueberham E, Brückner MK et al. Inducible neuronal expression of transgenic TGF-beta1 in vivo: dissection of short-term and long-term effects. Eur J Neurosci 2005; 22: 50-64.
30. Panza F, Solfrizzi V, Frisardi V et al. Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging 2009; 26: 537-555.
31. Holmes C, Boche D, Wilkinson D et al. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008; 372: 216-223.
32. Boche D, Zotova E, Weller RO et al. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain 2008; 131: 3299-3310.
33. Hawkes CA, Härtig W, Kacza J, Schliebs R, Weller RO, Nicoll JA and Carare RO. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol 2011; 121: 431-443.